Tag Archive: Novartis

Novartis pays big fine for bribing doctors in the US

2020-07-04

by

2020-07-04

Swiss pharma company Novartis will pay $729 million (CHF688 million) to US authorities in an out-of-court settlement over various charges, including that the company bribed doctors to use its drugs.

Read More »

Novartis withdraws patent claim on leukaemia treatment

2019-12-16

by

2019-12-16

Swiss pharmaceutical giant Novartis has backed down in a patent dispute over the leukaemia therapy Kymriah following opposition from NGOs. The Swiss NGO Public Eye is claiming victory in the European Patent Officeexternal link battle, but Novartis says the patent in question was only one of several it has in place on the (CAR)-T cell therapy treatment it had developed together with the University of Pennsylvania.

Read More »

Swiss firms give over CHF5 million a year to parties and candidates

2019-10-09

by

2019-10-09

Switzerland’s biggest firms – mainly banks, pharmaceutical firms and insurance companies - donate at least CHF5 million ($5 million) a year to political parties and candidates, a survey has revealed. The poll of 140 companies by Swiss public radio RTS, published on Tuesday, found that one in five firms donate regularly to political parties or politicians, to the tune of CHF5 million annually.

Read More »

Novartis Stockpiles Drugs in UK to Ensure Supply

2019-01-30

by

2019-01-30

Novartis Imports
Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure continuity of supply. In a press releaseexternal link on Friday, it said that after the British parliament’s rejection of Prime Minister Theresa May’s Brexit deal, “the risk of UK exiting the EU without a deal is increased and this will be hugely impactful for patients, particularly around the supply and...

Read More »

Novartis to cut 2,200 Swiss jobs by 2020

2018-09-27

by

2018-09-27

The pharmaceutical giant Novartis will cut about 2,200 jobs in Switzerland over the next four years. Nearly 1,500 jobs are affected in production and about 700 in services. This restructuring is part of the manufacturing strategy launched in 2015 to adapt the industrial base to a reduced product portfolio, announced Novartis on Tuesday. It currently employs 13,000 people across Switzerland.

Read More »

India’s Aurobindo buys Sandoz US assets from Novartis

2018-09-07

by

2018-09-07

Swiss pharmaceutical company Novartis announced the divestment of its dermatology and generic tablet portfolios of Sandoz US to India’s Aurobindo Pharma for a $900 million (CHF870 million) cash payment. A possible performance-related payment of $100 million could be added to the purchase price, the Swiss AWP financial news agency reported.

Read More »

Swiss Prosecutors will not Pursue Novartis over Trump Lawyer Payments

2018-06-09

by

2018-06-09

The Office of the Attorney General of Switzerland (OAG) announced on Wednesday that it will not bring proceedings against Novartis in connection with the payments the Swiss pharmaceutical company made to Donald Trump’s personal lawyer.

Read More »

Justice ministry confirms legal aid requests in Greece-Novartis scandal

2018-02-13

by

2018-02-13

Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials. The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed...

Read More »

Greek politicians named in Novartis scandal

2018-02-08

by

2018-02-08

Greece's parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis. The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based Novartisexternal link over nearly a decade to boost subscriptions of their products at public hospitals.

Read More »